These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38167259)

  • 21. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Advisory Committee on Immunization Practices' Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine - United States, 2020.
    McClung N; Chamberland M; Kinlaw K; Bowen Matthew D; Wallace M; Bell BP; Lee GM; Talbot HK; Romero JR; Oliver SE; Dooling K
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(47):1782-1786. PubMed ID: 33237895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can we move beyond vaccine apartheid? Examining the determinants of the COVID-19 vaccine gap.
    Forman L; Jackson C; Fajber K
    Glob Public Health; 2023 Jan; 18(1):2256822. PubMed ID: 37715686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scaling Up the Global COVID-19 Vaccination Program: Production, Allocation, and Distribution with an Emphasis on Equity.
    Louden EM
    Yale J Biol Med; 2022 Sep; 95(3):379-387. PubMed ID: 36187418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons learnt from the COVID-19 pandemic in selected countries to inform strengthening of public health systems: a qualitative study.
    Cardwell K; Clyne B; Broderick N; Tyner B; Masukume G; Larkin L; McManus L; Carrigan M; Sharp M; Smith SM; Harrington P; Connolly M; Ryan M; O'Neill M
    Public Health; 2023 Dec; 225():343-352. PubMed ID: 37979311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation.
    McGoldrick M; Gastineau T; Wilkinson D; Campa C; Clercq N; Mallia-Milanes A; Germay O; Krishnan J; Van Ooij M; Thien MP; Mlynarczyk PJ; Saltus E; Juvin P; Clenet D; Basso A; Dellepiane N; Pagliusi S; de Moraes Stávale MC; Sivaramakrishnan VH; Desai S
    Vaccine; 2022 Feb; 40(9):1215-1222. PubMed ID: 35180993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pandemics: Historically Slow "Learning Curve" Leading to Biomedical Informatics and Vaccine Breakthroughs.
    Kulikowski CA
    Yearb Med Inform; 2021 Aug; 30(1):290-301. PubMed ID: 33882592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 vaccines and the pandemic: lessons learnt for other neglected diseases and future threats.
    Hotez PJ; Gilbert S; Saville M; Privor-Dumm L; Abdool-Karim S; Thompson D; Excler JL; Kim JH
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37277196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.
    Hotez PJ; Batista C; Amor YB; Ergonul O; Figueroa JP; Gilbert S; Gursel M; Hassanain M; Kang G; Kaslow DC; Kim JH; Lall B; Larson H; Naniche D; Sheahan T; Shoham S; Wilder-Smith A; Sow SO; Strub-Wourgaft N; Yadav P; Bottazzi ME
    EClinicalMedicine; 2021 Sep; 39():101053. PubMed ID: 34368661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global Health System Resilience during Encounters with Stressors - Lessons Learnt from Cancer Services during the COVID-19 Pandemic.
    Yeoh K; Wu Y; Chakraborty S; Elhusseiny G; Gondhowiardjo S; Joseph N; Lee AWM; Loong HH; Msadabwe-Chikuni SC; Tan BF; Ospina AV; Roques T; Shum HM; Yeoh EK
    Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):e289-e300. PubMed ID: 36764875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.
    Assefa Y; Woldeyohannes S; Cullerton K; Gilks CF; Reid S; Van Damme W
    J Glob Health; 2022 Jul; 12():05021. PubMed ID: 35787525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public health ethics and the COVID-19 pandemic.
    Aliyu AA
    Ann Afr Med; 2021; 20(3):157-163. PubMed ID: 34558443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions.
    Towett G; Snead RS; Grigoryan K; Marczika J
    Global Health; 2023 Dec; 19(1):98. PubMed ID: 38066568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    Haldane V; Ariyarajah A; Berry I; Loutet M; Salamanca-Buentello F; Upshur REG
    PLoS One; 2023; 18(2):e0281358. PubMed ID: 36780502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
    Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
    Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inequity in access to vaccines: the failure of the global response to the COVID-19 pandemic.
    Ugalde A; Hellmann F; Homedes N
    Salud Colect; 2022 Oct; 18():e4190. PubMed ID: 36520487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
    Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
    Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity.
    Park SP; Lee HJ; Yu Y; Lee EYJ; Park YS
    BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 38035734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.